Comparison of the safety and pharmacokinetics of ST-246® after i.v. infusion or oral administration in mice, rabbits and monkeys.
<h4>Background</h4>ST-246® is an antiviral, orally bioavailable small molecule in clinical development for treatment of orthopoxvirus infections. An intravenous (i.v.) formulation may be required for some hospitalized patients who are unable to take oral medication. An i.v. formulation h...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2011
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/b5e19bc34bc24297a5169eda2e119b5a |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:b5e19bc34bc24297a5169eda2e119b5a |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:b5e19bc34bc24297a5169eda2e119b5a2021-11-18T06:47:59ZComparison of the safety and pharmacokinetics of ST-246® after i.v. infusion or oral administration in mice, rabbits and monkeys.1932-620310.1371/journal.pone.0023237https://doaj.org/article/b5e19bc34bc24297a5169eda2e119b5a2011-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21858040/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>ST-246® is an antiviral, orally bioavailable small molecule in clinical development for treatment of orthopoxvirus infections. An intravenous (i.v.) formulation may be required for some hospitalized patients who are unable to take oral medication. An i.v. formulation has been evaluated in three species previously used in evaluation of both efficacy and toxicology of the oral formulation.<h4>Methodology/principal findings</h4>The pharmacokinetics of ST-246 after i.v. infusions in mice, rabbits and nonhuman primates (NHP) were compared to those obtained after oral administration. Ten minute i.v. infusions of ST-246 at doses of 3, 10, 30, and 75 mg/kg in mice produced peak plasma concentrations ranging from 16.9 to 238 µg/mL. Elimination appeared predominately first-order and exposure dose-proportional up to 30 mg/kg. Short i.v. infusions (5 to 15 minutes) in rabbits resulted in rapid distribution followed by slower elimination. Intravenous infusions in NHP were conducted at doses of 1 to 30 mg/kg. The length of single infusions in NHP ranged from 4 to 6 hours. The pharmacokinetics and tolerability for the two highest doses were evaluated when administered as two equivalent 4 hour infusions initiated 12 hours apart. Terminal elimination half-lives in all species for oral and i.v. infusions were similar. Dose-limiting central nervous system effects were identified in all three species and appeared related to high C(max) plasma concentrations. These effects were eliminated using slower i.v. infusions.<h4>Conclusions/significance</h4>Pharmacokinetic profiles after i.v. infusion compared to those observed after oral administration demonstrated the necessity of longer i.v. infusions to (1) mimic the plasma exposure observed after oral administration and (2) avoid C(max) associated toxicity. Shorter infusions at higher doses in NHP resulted in decreased clearance, suggesting saturated distribution or elimination. Elimination half-lives in all species were similar between oral and i.v. administration. The administration of ST-246 was well tolerated as a slow i.v. infusion.Yali ChenAdams AmantanaShanthakumar R TyavanagimattDaniela ZimaX Steven YanGopi KasiMorgan WeeksMelialani A StoneWilliam C WeimersPeter SamuelYing TanKevin F JonesDaniel R LeeShirley S KicknerBradley M SavilleMartin LauzonAlan McIntyreKady M HoneychurchRobert JordanDennis E HrubyJanet M LeedsPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 8, p e23237 (2011) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Yali Chen Adams Amantana Shanthakumar R Tyavanagimatt Daniela Zima X Steven Yan Gopi Kasi Morgan Weeks Melialani A Stone William C Weimers Peter Samuel Ying Tan Kevin F Jones Daniel R Lee Shirley S Kickner Bradley M Saville Martin Lauzon Alan McIntyre Kady M Honeychurch Robert Jordan Dennis E Hruby Janet M Leeds Comparison of the safety and pharmacokinetics of ST-246® after i.v. infusion or oral administration in mice, rabbits and monkeys. |
| description |
<h4>Background</h4>ST-246® is an antiviral, orally bioavailable small molecule in clinical development for treatment of orthopoxvirus infections. An intravenous (i.v.) formulation may be required for some hospitalized patients who are unable to take oral medication. An i.v. formulation has been evaluated in three species previously used in evaluation of both efficacy and toxicology of the oral formulation.<h4>Methodology/principal findings</h4>The pharmacokinetics of ST-246 after i.v. infusions in mice, rabbits and nonhuman primates (NHP) were compared to those obtained after oral administration. Ten minute i.v. infusions of ST-246 at doses of 3, 10, 30, and 75 mg/kg in mice produced peak plasma concentrations ranging from 16.9 to 238 µg/mL. Elimination appeared predominately first-order and exposure dose-proportional up to 30 mg/kg. Short i.v. infusions (5 to 15 minutes) in rabbits resulted in rapid distribution followed by slower elimination. Intravenous infusions in NHP were conducted at doses of 1 to 30 mg/kg. The length of single infusions in NHP ranged from 4 to 6 hours. The pharmacokinetics and tolerability for the two highest doses were evaluated when administered as two equivalent 4 hour infusions initiated 12 hours apart. Terminal elimination half-lives in all species for oral and i.v. infusions were similar. Dose-limiting central nervous system effects were identified in all three species and appeared related to high C(max) plasma concentrations. These effects were eliminated using slower i.v. infusions.<h4>Conclusions/significance</h4>Pharmacokinetic profiles after i.v. infusion compared to those observed after oral administration demonstrated the necessity of longer i.v. infusions to (1) mimic the plasma exposure observed after oral administration and (2) avoid C(max) associated toxicity. Shorter infusions at higher doses in NHP resulted in decreased clearance, suggesting saturated distribution or elimination. Elimination half-lives in all species were similar between oral and i.v. administration. The administration of ST-246 was well tolerated as a slow i.v. infusion. |
| format |
article |
| author |
Yali Chen Adams Amantana Shanthakumar R Tyavanagimatt Daniela Zima X Steven Yan Gopi Kasi Morgan Weeks Melialani A Stone William C Weimers Peter Samuel Ying Tan Kevin F Jones Daniel R Lee Shirley S Kickner Bradley M Saville Martin Lauzon Alan McIntyre Kady M Honeychurch Robert Jordan Dennis E Hruby Janet M Leeds |
| author_facet |
Yali Chen Adams Amantana Shanthakumar R Tyavanagimatt Daniela Zima X Steven Yan Gopi Kasi Morgan Weeks Melialani A Stone William C Weimers Peter Samuel Ying Tan Kevin F Jones Daniel R Lee Shirley S Kickner Bradley M Saville Martin Lauzon Alan McIntyre Kady M Honeychurch Robert Jordan Dennis E Hruby Janet M Leeds |
| author_sort |
Yali Chen |
| title |
Comparison of the safety and pharmacokinetics of ST-246® after i.v. infusion or oral administration in mice, rabbits and monkeys. |
| title_short |
Comparison of the safety and pharmacokinetics of ST-246® after i.v. infusion or oral administration in mice, rabbits and monkeys. |
| title_full |
Comparison of the safety and pharmacokinetics of ST-246® after i.v. infusion or oral administration in mice, rabbits and monkeys. |
| title_fullStr |
Comparison of the safety and pharmacokinetics of ST-246® after i.v. infusion or oral administration in mice, rabbits and monkeys. |
| title_full_unstemmed |
Comparison of the safety and pharmacokinetics of ST-246® after i.v. infusion or oral administration in mice, rabbits and monkeys. |
| title_sort |
comparison of the safety and pharmacokinetics of st-246® after i.v. infusion or oral administration in mice, rabbits and monkeys. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2011 |
| url |
https://doaj.org/article/b5e19bc34bc24297a5169eda2e119b5a |
| work_keys_str_mv |
AT yalichen comparisonofthesafetyandpharmacokineticsofst246afterivinfusionororaladministrationinmicerabbitsandmonkeys AT adamsamantana comparisonofthesafetyandpharmacokineticsofst246afterivinfusionororaladministrationinmicerabbitsandmonkeys AT shanthakumarrtyavanagimatt comparisonofthesafetyandpharmacokineticsofst246afterivinfusionororaladministrationinmicerabbitsandmonkeys AT danielazima comparisonofthesafetyandpharmacokineticsofst246afterivinfusionororaladministrationinmicerabbitsandmonkeys AT xstevenyan comparisonofthesafetyandpharmacokineticsofst246afterivinfusionororaladministrationinmicerabbitsandmonkeys AT gopikasi comparisonofthesafetyandpharmacokineticsofst246afterivinfusionororaladministrationinmicerabbitsandmonkeys AT morganweeks comparisonofthesafetyandpharmacokineticsofst246afterivinfusionororaladministrationinmicerabbitsandmonkeys AT melialaniastone comparisonofthesafetyandpharmacokineticsofst246afterivinfusionororaladministrationinmicerabbitsandmonkeys AT williamcweimers comparisonofthesafetyandpharmacokineticsofst246afterivinfusionororaladministrationinmicerabbitsandmonkeys AT petersamuel comparisonofthesafetyandpharmacokineticsofst246afterivinfusionororaladministrationinmicerabbitsandmonkeys AT yingtan comparisonofthesafetyandpharmacokineticsofst246afterivinfusionororaladministrationinmicerabbitsandmonkeys AT kevinfjones comparisonofthesafetyandpharmacokineticsofst246afterivinfusionororaladministrationinmicerabbitsandmonkeys AT danielrlee comparisonofthesafetyandpharmacokineticsofst246afterivinfusionororaladministrationinmicerabbitsandmonkeys AT shirleyskickner comparisonofthesafetyandpharmacokineticsofst246afterivinfusionororaladministrationinmicerabbitsandmonkeys AT bradleymsaville comparisonofthesafetyandpharmacokineticsofst246afterivinfusionororaladministrationinmicerabbitsandmonkeys AT martinlauzon comparisonofthesafetyandpharmacokineticsofst246afterivinfusionororaladministrationinmicerabbitsandmonkeys AT alanmcintyre comparisonofthesafetyandpharmacokineticsofst246afterivinfusionororaladministrationinmicerabbitsandmonkeys AT kadymhoneychurch comparisonofthesafetyandpharmacokineticsofst246afterivinfusionororaladministrationinmicerabbitsandmonkeys AT robertjordan comparisonofthesafetyandpharmacokineticsofst246afterivinfusionororaladministrationinmicerabbitsandmonkeys AT dennisehruby comparisonofthesafetyandpharmacokineticsofst246afterivinfusionororaladministrationinmicerabbitsandmonkeys AT janetmleeds comparisonofthesafetyandpharmacokineticsofst246afterivinfusionororaladministrationinmicerabbitsandmonkeys |
| _version_ |
1718424375088119808 |